USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Growth Opportunities in the Oral Solid Dosage Formulation Industry
Growth Opportunities in the Oral Solid Dosage Formulation Industry
Personalized Medicine and Drug Delivery Technologies Enhance Future Growth Potential
RELEASE DATE
09-Apr-2024
09-Apr-2024
REGION
North America
North America
Research Code: PFI7-01-00-00-00
SKU: HC_2024_658
$2,450.00
In stock
SKU
HC_2024_658
Description
This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It identifies the most prevalent and emerging business models supporting industry stakeholders in enhancing their competitiveness and service offerings. Discussions on key industry drivers and restraints, partnerships, investment and consolidation activities, disruptive technologies, recent excipient advancements, and present and future trends shed light on the industry’s growth potential. Industry use cases will provide brief insights into game-changing participants working toward developing disruptive technologies and patient-centric drugs. The analysis will also help uncover growth opportunities based on megatrends and business models, clinical needs, use cases, market access strategies, and technology trends.
Research Highlights:
- Impact of strategic imperatives on the industry
- Growth drivers and restraints
- Oral solid dosage based on API release profile
- R&D pipeline and product innovations
- Small molecule oral dosage market overview
- Small molecule oral solid dosage formulation by therapy area
- Innovations in extended-release dosage forms
- Industry trends and emerging technologies
- Supply chain resilience strategies – focus areas
- Investment trends – Expansion and capability-building initiatives
- Consolidation trends – mergers & acquisitions
- company benchmarking
- oral drug delivery solutions & services
- Growth opportunities
Author: Supriya Lala Kundu
Table of Contents
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Oral Solid Dosage Formulation Industry
Scope of Analysis
Industry Definition and Segmentation
Definition—OSD Based on API Release Profile
Growth Drivers
Growth Restraints
R&D Pipeline and Product Innovations
Small Molecule Oral Dosage Formulation Industry Overview
Small Molecule Oral Dosage Formulation Industry Overview (continued)
Small Molecule OSD Formulation by Therapy Area
Small Molecule OSD Formulation Therapy Area by Dosage Form
Innovations in Extended Release Dosage forms
Industry Trends and Emerging Technologies
Industry Trends and Emerging Technologies (continued)
Industry Trends and Emerging Technologies (continued)
Industry Trends and Emerging Technologies (continued)
Industry Trends and Emerging Technologies (continued)
Industry Trends and Emerging Technologies (continued)
Industry Trends and Emerging Technologies (continued)
Regional Policies and Initiatives
Regional Policies and Initiatives (continued)
Regional Policies and Initiatives (continued)
Regional Policies and Initiatives (continued)
OSD Manufacturing—Production Flow
OSD Manufacturing—Production Flow (continued)
Vendor Ecosystem
Small Molecule OSD CDMO Industry Revenue
OSD CDMO Industry Overview
Supply Chain Resilience Strategies—Focus Areas
Investment Trends—Expansion and Capability Building
Investment Trends—Expansion and Capability Building (continued)
Consolidation Trends—Mergers & Acquisitions
Growth Themes and Business Models
Company Benchmarking—Oral Drug Delivery Solutions and Services
Company Benchmarking Analysis
Company Benchmarking Analysis (continued)
Companies to Watch
Companies to Watch (continued)
Growth Opportunity 1: Fixed Dose Combination Products for Chronic Diseases
Growth Opportunity 1: Fixed Dose Combination Products for Chronic Diseases (continued)
Growth Opportunity 2: Medical Cannabidiol
Growth Opportunity 2: Medical Cannabidiol (continued)
Growth Opportunity 3: Phase-appropriate Services for Orphan Drugs
Growth Opportunity 3: Phase-appropriate Services for Orphan Drugs (continued)
Growth Opportunity 4: Additive Manufacturing for Personalized Medicine
Growth Opportunity 4: Additive Manufacturing for Personalized Medicine (continued)
Best Practices Recognition
Frost Radar
Benefits and Impacts of Growth Opportunities
Next Steps
Take the Next Step
List of Exhibits
Legal Disclaimer
This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It identifies the most prevalent and emerging business models supporting industry stakeholders in enhancing their competitiveness and service offerings. Discussions on key industry drivers and restraints, partnerships, investment and consolidation activities, disruptive technologies, recent excipient advancements, and present and future trends shed light on the industry s growth potential. Industry use cases will provide brief insights into game-changing participants working toward developing disruptive technologies and patient-centric drugs. The analysis will also help uncover growth opportunities based on megatrends and business models, clinical needs, use cases, market access strategies, and technology trends.--BEGIN PROMO--
Research Highlights:
- Impact of strategic imperatives on the industry
- Growth drivers and restraints
- Oral solid dosage based on API release profile
- R&D pipeline and product innovations
- Small molecule oral dosage market overview
- Small molecule oral solid dosage formulation by therapy area
- Innovations in extended-release dosage forms
- Industry trends and emerging technologies
- Supply chain resilience strategies – focus areas
- Investment trends – Expansion and capability-building initiatives
- Consolidation trends – mergers & acquisitions
- company benchmarking
- oral drug delivery solutions & services
- Growth opportunities
Author: Supriya Lala Kundu
| Author | Supriya Lala Kundu |
|---|---|
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Podcast | No |
| WIP Number | PFI7-01-00-00-00 |